Worldwide Flight Services (WFS) has announced that is investing €10 million in a new 25,833 sq ft (2,400 m²) pharma centre to expand its range of services for airline and freight forwarder customers at Paris Charles de Gaulle Airport. The company said the investment also includes equipment and supplies for the next ten years.
Opening in September 2019, it will be the only facility owned by a ground handler dedicated to pharmaceuticals at Paris Charles de Gaulle (IATA: CDG).
This latest investment follows the opening of WFS pharma facilities in Copenhagen, Johannesburg and Miami.
The Pharma Centre offers both landside and airside acceptance capabilities and will be fully GDP compliant when it opens. It will also become IATA CEIV Pharma certified, as part of an initiative launched by Group ADP within the cargo community at Paris-CDG Airport, to fully support WFS’ dedicated temperature-controlled service to maintain strict control of the distribution chain, therefore protecting the quality and integrity of healthcare and life science products.